Management of the overdose of paliperidone 3-monthly injection: A case report

被引：0
|
作者：
Jin, Fei Xue [1 ]
Malik, Asad [2 ]
机构：
[1] Northern Sydney Local Hlth Dist, Sydney, NSW, Australia
[2] Napean Blue Mt Older Persons Mental Hlth Serv, Kingswood, NSW, Australia
来源：
AUSTRALASIAN PSYCHIATRY | 2023年 / 31卷 / 03期
关键词：
D O I：
10.1177/10398562231162233
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：405 / 405
页数：1
相关论文
共 50 条
  • [21] Non-Fatal Paliperidone Overdose: A Case Report
    Gill, Jesjeet Singh
    Pillai, Subash Kumar
    Koh, Ong Hui
    Jambunathan, Stephen
    TURK PSIKIYATRI DERGISI, 2010, 21 (04) : 331 - 333
  • [22] Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation
    Corbeil, Olivier
    Essiambre, Anne-Marie
    Bechard, Laurent
    Roy, Audrey-Anne
    Huot-Lavoie, Maxime
    Brodeur, Sebastien
    Chandrasena, Ranjith
    Theriault, Chantale
    Crocker, Candice
    Melun, Jean-Pierre
    Tibbo, Phil
    Demers, Marie-France
    Roy, Marc-Andre
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2022, 12
  • [23] SYMPTOMATIC REMISSION WITH PALIPERIDONE PALMITATE 3-MONTHLY FORMULATION IN SCHIZOPHRENIA PATIENTS IN A CLINICAL PRACTICE SETTING
    Garcia-Portilla, M. P.
    Llorca, P. M.
    Maina, G.
    Bozikas, V. P.
    Devrimci-Ozguven, H.
    Kim, S. W.
    Bergmans, P.
    Usankova, I.
    Cherubin, P.
    Najarian, Dean
    Pungor, K.
    SCHIZOPHRENIA BULLETIN, 2019, 45 : S295 - S296
  • [24] Use of 3-monthly long-acting injectable paliperidone on acute inpatient psychiatric unit
    Hernandez Huerta, D.
    Soto-Ruano, A.
    Montes-Rodriguez, J. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S392 - S393
  • [25] “Real world” clinical effectiveness of paliperidone palmitate 3-monthly injectable in early psychosis patients
    Vincent Ferraro
    Simon Lafrenière
    Marie-France Demers
    Marc-André Roy
    Amal Abdel-Baki
    Psychopharmacology, 2020, 237 : 3795 - 3797
  • [26] Clinical management of medication overdose: Three-monthly paliperidone palimitate injectable medication
    Parker, Robert
    Vellar, Kane
    Khalid, Usman
    Wood, Daniel
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2022, 56 (04): : 413 - 413
  • [27] Cost-effectiveness analysis of monthly, 3-monthly, and 6-monthly long-acting injectable and oral paliperidone in adults with schizophrenia
    Wang, Grace Hsin-Min
    Svensson, Mikael
    Shao, Hui
    Vouri, Scott Martin
    Park, Haesuk
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2023, 29 (08): : 884 - 895
  • [28] Impact on carer burden when stable patients with schizophrenia transitioned from 1-monthly to 3-monthly paliperidone palmitate
    Lencer, Rebekka
    Paz Garcia-Portilla, Maria
    Bergmans, Paul
    Gopal, Srihari
    Mathews, Maju
    Wooller, Annette
    Pungor, Katalin
    COMPREHENSIVE PSYCHIATRY, 2021, 107
  • [29] Paliperidone Palmitate 3-Monthly Versus 1-Monthly Injectable in Patients With Schizophrenia With or Without Prior Exposure to Oral Risperidone or Paliperidone: A Post Hoc, Subgroup Analysis
    Maju Mathews
    Huiling Pei
    Adam Savitz
    Isaac Nuamah
    David Hough
    Larry Alphs
    Srihari Gopal
    Clinical Drug Investigation, 2018, 38 : 695 - 702
  • [30] Paliperidone Palmitate 3-Monthly Versus 1-Monthly Injectable in Patients With Schizophrenia With or Without Prior Exposure to Oral Risperidone or Paliperidone: A Post Hoc, Subgroup Analysis
    Mathews, Maju
    Pei, Huiling
    Savitz, Adam
    Nuamah, Isaac
    Hough, David
    Alphs, Larry
    Gopal, Srihari
    CLINICAL DRUG INVESTIGATION, 2018, 38 (08) : 695 - 702
12345